StonvexLoading…
StonvexStonvexStonvexCore line items from PRPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $24.25M | $18.58M | $15.41M | $9.82M |
Operating Income | $-1.20M | $-4.22M | $-7.62M | $-12.80M |
Net Income | $-363.00K | $-4.29M | $-5.85M | $-12.18M |
EPS (Diluted) | $-0.23 | $-2.93 | $-4.51 | $-10.73 |
Total Assets | $21.32M | $17.00M | $18.10M | $21.50M |
Total Liabilities | $6.76M | $4.90M | $3.67M | $5.14M |
Cash & Equivalents | $2.65M | $1.39M | $1.50M | $3.44M |
Free Cash Flow OCF − CapEx | $359.00K | $216.00K | $-3.69M | $-8.00M |
Shares Outstanding | 1.78M | 1.49M | 1.42M | 1.14M |